Colgate Weighs $1 Billion Personal Care Brand Sale

Colgate-Palmolive generated about $20.4 billion in annual sales, making a potential sale worth slightly more than $1 billion relatively small compared with the company’s roughly $70 billion market capitalization.
The personal-care unit includes more than the brands reportedly under review: its portfolio also covers shower gels and skin-care products, alongside deodorants and liquid and bar soaps.
Colgate’s latest quarterly results showed net sales rising 4.9%, but organic sales in North America fell 3%, underscoring the regional pressure behind the company’s stated turnaround effort.
The potential sale follows a broader consumer-goods industry trend: Unilever has agreed to sell its food business to McCormick for $45 billion, spun off its Magnum ice-cream unit and sold more than 20 beauty and personal-care brands to Yellow Wood Partners in 2024; Nestlé has also agreed to sell its vitamins business to Yellow Wood for about $1 billion.
The brands under consideration are described as established mass-market staples rather than failed products, suggesting the review is primarily about portfolio priorities and growth prospects rather than an immediate brand crisis.
Colgate-Palmolive is exploring the sale of three major personal-care brands — Softsoap, Irish Spring, and Speed Stick — in a deal that could fetch over $1 billion, according to Inshorts. The move signals the company's push to focus on its strongest business: oral care, which generates nearly half of Colgate's $20.4 billion in annual sales. Trading View reports the sale review is advised by Goldman Sachs and comes as consumer-goods companies face tariffs, cautious spending, and higher costs.
The divestiture reflects Colgate's effort to turnaround its struggling North America business. Recent earnings showed organic sales in the region fell 3%, even as overall net sales rose 4.9%. Personal care currently accounts for about 17% of company sales, far less crucial than the oral-care division that the company wants to prioritize.
Colgate wants to sharpen its focus on oral care, the company's most profitable engine. Oral care generates roughly 50% of revenue — far more than personal care's 17%. By selling Softsoap, Irish Spring, and Speed Stick, Colgate frees up cash and management attention for higher-growth opportunities.
The brands under review are established mass-market staples, not struggling products. Trading View notes this suggests the sale is about portfolio strategy and growth priorities — not a brand crisis. Colgate is choosing to exit, not forced out.
Colgate's North American business is weighing on overall performance. Organic sales in the region dropped 3% in the latest quarter, even as global net sales climbed 4.9%. The company has publicly described its North America recovery as a long-term effort, signaling that major changes are needed.
The personal-care unit generates lower margins and faces intense competition from rivals in soaps and deodorants. Divesting these mass-market brands lets Colgate redirect resources toward higher-margin oral-care products where it holds stronger competitive advantages.
Colgate's review fits a larger trend in consumer goods. Yahoo Finance notes that Unilever sold its food business to McCormick for $45 billion and divested over 20 beauty and personal-care brands to Yellow Wood Partners in 2024. Nestlé sold its vitamins business to Yellow Wood for about $1 billion. Major companies are trimming portfolios to focus on core strengths.
These divestitures reflect industry headwinds: tariff pressure, cautious consumer spending, and rising input costs. Consumer-goods firms are betting that leaner, more focused portfolios will perform better in a tougher economic environment.
A $1 billion sale would be meaningful but not transformational. Colgate's market cap sits around $70 billion. Annual sales total $20.4 billion, making the potential divestiture slightly larger than 5% of yearly revenue. The deal would not reshape the company, but signals strategic intent.
No deal is guaranteed. Both Colgate and Goldman Sachs declined to comment on the review. If a sale proceeds, expect the timeline to stretch into late 2025 or beyond as buyers conduct due diligence on the three established brands.
Publishers
12
Articles
120
Reach
132